-
Product Insights
NewHypoxia Inducible Factor 2 – Drugs In Development, 2024
The Hypoxia Inducible Factor 2 pipeline drugs market research report outlays comprehensive information on the Hypoxia Inducible Factor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Genetic Disorders, and Undisclosed which include indications of Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Pulmonary Arterial Hypertension, Von Hippel-Lindau Syndrome, and Unspecified Rare Disease. It also reviews...
-
Product Insights
NewMucolipin 1 – Drugs In Development, 2024
The Mucolipin 1 pipeline drugs market research report outlays comprehensive information on the Mucolipin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Undisclosed, and Musculoskeletal Disorders which include indications of Neurodegenerative Diseases, Parkinson's Disease, Lysosomal Storage Disorder, Niemann-Pick Disease Type C, Unspecified Rare Disease, and Muscular Dystrophy. It also reviews key...
-
Product Insights
NewPhosphodiesterase 9 – Drugs In Development, 2024
The Phosphodiesterase 9 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Hematological Disorders, and Undisclosed which include indications of Congestive Heart Failure (Heart Failure), Systolic Heart Failure, Alzheimer's Disease, Parkinson's Disease, Sickle Cell Disease, Thalassemia, and Unspecified Rare Disease. It also...
-
Product Insights
NewRAC Beta Serine/Threonine Protein Kinase – Drugs In Development, 2024
The RAC Beta Serine/Threonine Protein Kinase pipeline drugs market research report outlays comprehensive information on the RAC Beta Serine/Threonine Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Non Malignant Disorders, Undisclosed, and Hematological Disorders which include indications of Prostate Cancer, Solid Tumor, Proteus Syndrome, Unspecified Rare Disease, and Sickle Cell Disease. It also reviews...
-
Product Insights
NewPolycomb Protein EED – Drugs In Development, 2024
The Polycomb Protein EED pipeline drugs market research report outlays comprehensive information on the Polycomb Protein EED targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Hematological Disorders, and Undisclosed which include indications of Diffuse Large B-Cell Lymphoma, Solid Tumor, Anemia, Sickle Cell Disease, and Unspecified Rare Disease. It also reviews key players involved in Polycomb Protein...
-
Product Insights
NewInterferon Induced Double Stranded RNA Activated Protein Kinase – Drugs In Development, 2024
The Interferon Induced Double Stranded RNA Activated Protein Kinase pipeline drugs market research report outlays comprehensive information on the Interferon Induced Double Stranded RNA Activated Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Oncology, and Undisclosed which include indications of Alzheimer's Disease, Dementia, Unspecified Influenza Virus Infections, Breast Cancer, Prostate...
-
Product Insights
NewRAC Gamma Serine/Threonine Protein Kinase – Drugs In Development, 2024
The RAC Gamma Serine/Threonine Protein Kinase pipeline drugs market research report outlays comprehensive information on the RAC Gamma Serine/Threonine Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Non Malignant Disorders, Undisclosed, and Hematological Disorders which include indications of Endometrial Cancer, Triple-Negative Breast Cancer (TNBC), Proteus Syndrome, Unspecified Rare Disease, and Sickle Cell Disease. It...
-
Product Insights
NewRAC Alpha Serine/Threonine Protein Kinase – Drugs In Development, 2024
The RAC Alpha Serine/Threonine Protein Kinase pipeline drugs market research report outlays comprehensive information on the RAC Alpha Serine/Threonine Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Non Malignant Disorders, Undisclosed, and Hematological Disorders which include indications of Solid Tumor, Triple-Negative Breast Cancer (TNBC), Proteus Syndrome, Unspecified Rare Disease, and Sickle Cell Disease. It...
-
Product Insights
NewTyrosine Protein Phosphatase Non Receptor Type Substrate 1 – Drugs In Development, 2024
The Tyrosine Protein Phosphatase Non Receptor Type Substrate 1 pipeline drugs market research report outlays comprehensive information on the Tyrosine Protein Phosphatase Non Receptor Type Substrate 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Undisclosed, and Gastrointestinal which include indications of Unspecified Cancer, Solid Tumor, Autoimmune Disorders, Unspecified Rare Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH),...
-
Product Insights
NewEndothelial PAS Domain Containing Protein 1 – Drugs In Development, 2024
The Endothelial PAS Domain Containing Protein 1 pipeline drugs market research report outlays comprehensive information on the Endothelial PAS Domain Containing Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Cardiovascular, Genetic Disorders, and Undisclosed which include indications of Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Pulmonary Arterial Hypertension, Von Hippel-Lindau Syndrome, and Unspecified Rare...